Esperion Therapeutics Inc. (ESPR) Dividend History
Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.
Last update 12/11/2023
Dividend Yield Summary
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 43.66 | 40.95 | 18.89 | 6.01 | 2.37 | - |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |